Lineus Medical Adds New VP of Sales, Larry Hayes
Wisconsin Eagle/10274224

FAYETTEVILLE, Ark. - WisconsinEagle -- Lineus Medical announces that it has added a new executive team member with the hiring of Larry Hayes from Richmond, VA. Larry joins Lineus Medical as Vice President of Sales and leads all sales related efforts for the company.

Larry has over 20 years of experience across the medical device and medical technology field and has worked with 4 different successful early-stage startups. Before becoming Vice President of Sales at Lineus Medical, he was the Vice President Interventional Imaging at GE Healthcare where he led commercial teams in the United States and Canada for GE's Interventional Imaging Systems. He was the Vice President of International Sales, Marketing, and Commercial Strategy at IntroCare where he grew their global sales, and improved their marketing, commercial, regulatory, and medical affairs functions. Larry spent 8 years working abroad growing international sales and relations at EziSurg Medical and Vascular Flow Technologies. Prior to his international experience, Larry held several sales management positions at Banyan Biomarkers and W.L Gore & Associates. He earned a Bachelor of Arts in English at Catawba College.

More on Wisconsin Eagle

• Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
• Cybersecurity is Protecting Your Personal Information and Your Portfolio
• L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
• Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
• Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs

The CEO of Lineus Medical, Vance Clement, stated "Larry has a vast experience with startup companies in motivating and leading sales teams.  We have a great product and a good base of customers, and we are excited to work with Larry as we take sales to new heights."

"I'm very excited to join the talented team at Lineus Medical," said Larry Hayes. "The clinical results of the company's flagship product, SafeBreak Vascular, showed significant improvements over the current standard of care, with promising health-economic outcomes that benefit clinicians and their patients¹. I'm looking forward to optimizing our commercial strategy and growing sales significantly."

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money. ¹ It's a win-win-win.

More on Wisconsin Eagle

• The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
• $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
• When The Call Hits Home Podcast Features Tom Rizzo
• SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
• New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

1.      Data on File

MKG 0269 Rev 00